Status:
COMPLETED
New Strategies of Genetic Study of Patients With Oculocutaneous Albinism
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Oculocutaneous Albinism
Mutation
Eligibility:
All Genders
Brief Summary
The oculocutaneous albinism is an autosomal recessive condition associated with mutations in 4 genes. In 20% of patients no mutation is identified. The optimization of genetic analysis methods and the...
Detailed Description
The oculocutaneous albinism is an autosomal recessive condition associated with mutations in 4 genes. In 20% of patients no mutation is identified. The optimization of genetic analysis methods and the...
Eligibility Criteria
Inclusion
- Oculocutaneous albinism (diagnosis validated by a clinician at the initial genetic consultation and did not show mutations of the TYR, OCA2, TYRP1, SLC45A2 genes)
Exclusion
- None
Key Trial Info
Start Date :
September 15 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2010
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04068961
Start Date
September 15 2010
End Date
October 31 2010
Last Update
August 28 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.